Chinese authority in HKSAR issues easier visa policy for foreigners inoculated with Chinese vaccine
Liu Caiyu Published: Mar 14, 2021 08:25 PM
Residents wait to get vaccinated as the Hong Kong Special Administrative Region starts mass COVID-19 vaccination on February 26. Photo: cnsphotoChina has simplified its visa policy for foreigners applying to enter the Chinese mainland via Hong Kong who have received China-produced COVID-19 vaccines, which experts said shows the authorities confidence in the efficacy and safety of the Chinese vaccines and will facilitate personnel exchanges.
The Office of the Commissioner of the Chinese Ministry of Foreign Affairs in the Hong Kong Special Administrative Region issued a notice on Friday to exempt foreign visa applicants who have received a Chinese vaccine from providing health certification. Chinese experts said it can be seen as a trial for China to explore vaccine visas and hopefully can be expanded to other places.
Covid Vaccine Developed by China’s Zhifei Enters Phase III Trials in Uzbekistan Xu Wei Covid Vaccine Developed by China’s Zhifei Enters Phase III Trials in Uzbekistan
(Yicai Global) Dec. 11 A Covid-19 vaccine developed by Chongqing Zhifei Biological Products began Phase III human trials in Uzbekistan yesterday, making the Central Asian country the first to kick off the shot’s global third-stage tests.
Some 5,000 volunteers will take part in testing the recombinant vaccine, which was developed by Anhui Zhifei Longcom Biopharmaceutical, a wholly owned subsidiary of Zhifei Biological, and the Institute of Microbiology under the Chinese Academy of Sciences.